Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Acute treatments for migraine: final policy recommendations
Acute treatments for migraine: final policy recommendations
Following its deliberation on the evidence, the Midwest CEPAC Panel engaged in a moderated discussion with a policy roundtable about how best to apply the evidence on the use of lasmiditan, ubrogepant, and rimegepant for acute treatment of migraine. The policy roundtable members included two patient advocates, two clinical experts, two payers, and three representatives from pharmaceutical manufacturers. The discussion reflected multiple perspectives and opinions, and therefore, none of the statements below should be taken as a consensus view held by all participants. All Policy Roundtable participants and conflict of interest disclosures for all meeting participants can be found in the Appendix of this document.
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)